Kinetic modeling of benzodiazepine receptor binding with PET and high specific activity [11C]iomazenil in healthy human subjects

Synapse

Volumn 35, Issue 1, 2000, Pages 68-77

  Bremner, J Douglas ^a,b,d   Horti, Andrew ^c   Staib, Lawrence H ^a   Zea Ponce, Yolanda ^a   Soufer, Robert ^a   Charney, Dennis S ^a,b   Baldwin, Ronald ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Benzodiazepines; Iomazenil; Modeling; Neuroimaging; PET

Indexed keywords

BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR; CARBON 11; IOMAZENIL; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; HUMAN; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY;

ADOLESCENT; ADULT; BRAIN; CARBON RADIOISOTOPES; FLUMAZENIL; HUMANS; KINETICS; MALE; RADIOLIGAND ASSAY; RECEPTORS, GABA-A; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033991083     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(200001)35:1<68::AID-SYN9>3.0.CO;2-H     Document Type: Article

References (38)

1. d values with positron emission tomography. Eur J Pharmacol 213:107-115.
2. 123I]iomazenil: Kinetic and equilibrium paradigms. J Nucl Med 35:228-238.
3. 123I]iomazenil. J Nucl Med 36:167-175.
4. Akaike H. 1974. A new look at the statistical model identification. IEEE Trans Automat Contr AC 19:716-723.
5. 11C]iomazenil. Nucl Med Biol 22:659-665.
6. Beer H-F, Blauenstein PA, Hasler PH, Delaloye B, Riccabona G, Bangerl I, Hunkeler W, Bonetti EP, Pieri L, Richards JG, Schubiger PA. 1990. In vitro and in vivo evaluation of iodine-123 Ro 16-154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 31:1007-1014.
7. Blomqvist G, Pauli S, Farde L, Eriksson L, PerssonA, Halldin C. 1990. Maps of receptor binding parameters in the human brain: a kinetic analysis of PET measurements. Eur J Nucl Med 16:257-265.
8. Brouillet E, Chavoix C, Khalili-Varasteh M, Bottlaender M, Hantraye P, Yorke J-C, Maziere M. 1990. Quantitative evaluation of benzodiazepine receptors in live Papio papio using positron emission tomography. Mol Pharmacol 38:445-451.
9. Buck A, Western G, Gustav K, vonSchulthess, Burger C. 1996. Modeling alternatives for cerebral carbon-11-iomazenil kinetics. J Nucl Med 37:699-705.
10. Carson RE. 1991. The development and application of mathematical models in nuclear medicine. J Nucl Med 32:2206-2208.
11. Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilbourn MR, Kuhl DE. 1991. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann Neurol 30:663-672.
12. Gandelman M, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Innis RB. 1994. Evaluation of ultrafiltration for the free fraction determination of SPECT radiotracers:β-CIT, IBF, and iomazenil. J Pharm Sci 83:1014-1019.
13. 11C]flumazenil. J Cereb Blood Flow Metab 11:745-752.
14. Innis RB, Al-Tikriti MS, Zoghbi SS, Baldwin RM, Sybirska EH, Laruelle MA, Malison RT, Seibyl JP, Zimmermann RC, Johnson EW, Smith EO, Charney DS, Heninger GR, Woods SW, Hoffer PB. 1991. SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves. J Nucl Med 32:1654-1761.
15. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 11:735-744.
16. Koepp MJ, Richardson MP, brookds DJ, Poline JB, Van Paessehen W, Friston KJ, Duncan JS. 1996. Cerebral benzodiazepine receptors in hippocampal sclerosis: An objective in vivo analysis. Brain 119:1677-1687.
17. 123I]iomazenil binding to benzodiazepine receptors in nonhuman primates. I. Kinetic modeling of single bolus experiments. J Cereb Blood Flow Metab 14:439-452.
18. Millet P, Delforge J, Mauguiere F, Pappata S, Cinotti L, Frouin V, Samson Y, Bendriem B, Syrota A. 1995. Parameter and index images of benzodiazepine receptor concentration in the brain. J Nucl Med 36:1462-1471.
19. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. 1984. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15:217-227.
20. Mulaney NA, Gould LK, Hartz RK, Hitchens RE, Wong WH, Bristow D, Adler S, Philippe EA, Bendrien B, Sanders M, Gibbs B. 1990. Design and performance of Posicam 6.5 BGO Positron camera. J Nucl Med 31:610-616.
21. Onishi Y, Yonekura Y, Mukai T, Nishizawa S, Tanaka F, Okazawa H, Ishizu, K, Fujita T, Shibasaki H, Konishi J. 1995. Simple quantification of benzodiazepine receptor binding and ligand transport using iodine-123-iomazenil and two SPECT scans. J Nucl Med 36:1201-1210.
22. Onishi Y, Yonekura Y, Nishizawa S, Tanaka F, Okazawa H, Ishizu, K, Fujita T, Konishi J, Mukai T. 1996a. Noninvasive quantification of iodine-123-iomazenil SPECT. J Nucl Med 37:374-378.
23. Onishi Y, Yonekura Y, Tanaka F, Nishizawa S, Okazawa H, Ishizu, K, Fujita T, Konishi J, Mukai T. 1996b. Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: the optimal scan time. Eur J Nucl Med 23:1491-1497.
24. Pappata S, Samson Y, Chavoix C, Prenant C, Maziere M, Baron JC. 1988. Regional specific binding of [11C]Ro 15-1788 to central type benzodiazepine receptors in human brain: quantitative evaluation by PET. J Cereb Blood Flow Metab 8:304-313.
25. Persson A, Ehrin E, Eriksson L, Farde L, Hedstrom, Litton J-E, Mindus P, Sedvall G. 1985. Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. J Psychiatr Res 19:609-622.
26. Pike VW, Halldin C, Crouzel C, Barre L, Nutt DJ, Osman S, Shah F, Turton DR, Waters SL. 1993. Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites: current status. Nucl Med Biol 20:503-525.
27. 11C]flumazenil. J Cereb Blood Flow Metab 13:656-667.
28. Samson Y, Hantraye P, Baron JC, Soussaline F, Comar D, Maziere M. 1985. Kinetics and displacement of [C-11]Ro 15-1788, a benzodiazepine antagonist studied in human brain in vivo by positron tomography. Eur J Pharmacol 110:247-251.
29. Sandberg IW. 1978. On the mathematical foundations of compartmental analysis in biology, medicine, and ecology. IEEE Trans Circuits Syst CAS-25:273-279.
30. Savic I, Roland P, Sedvall G, Persson A, Pauli S, Wilden L. 1988. In vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 2:863-866.
31. Shinotoh H, Yamasaki T, Inoue O, Itoh T, Suzuki K, Hasimoto K, Tateno Y, Ikehira H. 1986. Visualization of specific binding sites of benzodiazepine. J Nucl Med 27:1593-1599.
32. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897-916.
33. Spitzer RL, Williams JBW, Gibbon M. 1987. Structured clinical interview for DSMIIIR. New York: New York State Psychiatric Institute, Biometrics Research Department.
34. 123I]iomazenil SPECT imaging demonstates significant benzodiazepine receptor reserve in human and nonhuman primate brain. Neuropharmacology 32:671-680.
35. 11C]iomazenil. J Lab Compound Radiopharm 32:169-170.
36. Westera G, Buck A, Burger C, Leenders KL, von Schulthess GK, Schubiger AP. 1996. Carbon-11 and iodine-123 labelled iomazenil: a direct PET-SPECT comparison. Eur J Nucl Med 23:5-12.
37. 123I]iomazenil: implications for the reaction mechanism. Int J Appl Radiat lost 45:63-68.
38. 123I]iomazenil in human and nonhuman primates. Nucl Med Biol 19:881-888.